Association of Dynamic Changes in Peripheral Blood Indexes With Response to PD-1 Inhibitor-Based Combination Therapy and Survival Among Patients With Advanced Non-Small Cell Lung Cancer

BACKGROUND: PD-1 inhibitors have been routinely used in the treatment of advanced non-small cell lung cancer (NSCLC), and have demonstrated to significantly improve survivorship when combining with other conventional therapies, such as chemotherapy and anti-angiogenesis therapy. PD-L1 is the most co...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yuzhong, Wen, Shaodi, Xia, Jingwei, Du, Xiaoyue, Wu, Yuan, Pan, Banzhou, Zhu, Wei, Shen, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161505/
https://www.ncbi.nlm.nih.gov/pubmed/34054853
http://dx.doi.org/10.3389/fimmu.2021.672271

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161505/
https://www.ncbi.nlm.nih.gov/pubmed/34054853
http://dx.doi.org/10.3389/fimmu.2021.672271

Ejemplares similares